SCHEMBL5726424

SCHEMBL5726424

COC(=O)CSc1ncc(Cc2cccs2)c(N)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ALDH1A1 P00352 7/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MIF P14174 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ LMNA P02545 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726367 0.89 ABCB1 (0.50) MAPTHIF1AALDH1A1MEN1KMT2A
SCHEMBL5726352 0.81 LRRK2 (0.42) MAPTALDH1A1KMT2AL3MBTL1LMNA
SCHEMBL5726595 0.76 ALDH1A1 (0.42) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5726333 0.76 MAPT (0.41) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5726650 0.76 TP53 (0.48) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5726244 0.75 PIK3CD (0.36) ALDH1A1MAPK1ALOX15
SCHEMBL5727637 0.74 ALDH1A1 (0.40) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5726530 0.72 PIK3CD (0.37) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5726249 0.72 ABCB1 (0.47) MAPTHIF1AALDH1A1KMT2AKDM4E
SCHEMBL5725943 0.72 ABCB1 (0.48) MAPTHIF1AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138404-B2 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-21 — — US claimed
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP claimed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP claimed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US claimed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO claimed
US-7138404-B2 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-21 — — US disclosed
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP disclosed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP disclosed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US disclosed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022907-A1 4-aminopyrimidine derivatives GRM5, GRIK5, GRM1 MAPT 2205/4885HIF1A 3259/4885ALDH1A1 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback